News

Validation agreement signed between EPO and Cambodia

On 23 January 2017, a validation agreement was signed between the Royal Government of the Kingdom of Cambodia and the European Patent Organisation to extend, upon request of the applicant, European patent applications and patents to Cambodia. The agreement has not yet entered into force but is expected to do...

Read more

Italy ratifies Agreement on Unified Patent Court

Italy has ratified the Agreement on the Unified Patent Court (UPC) bringing the number of countries to have ratified the Agreement to twelve (confirmation can be found here). With the UPC Agreement currently unable to come into effect until the UK and Germany have also ratified the Agreement, it is...

Read more

Incredible! – The Plausibility Threshold for the Technical Effect is Raised by the EPO – T688/16

Last week saw the revocation of Bristol-Myers Squibb’s (BMS) European patent no. 1169038, which claimed the $1.6 billion a year anti-cancer drug dasatinib, aka Sprycel®. GJE partner, Arnie Clarke, who was representing an opponent in these proceedings, explains the decision and its potentially far-reaching consequences. Background and Issues The patent...

Read more

Recognition for GJE’s Trade Mark partners by World Trademark Review

We are delighted to report that the 2017 edition of World Trademark Review recognises the strength of our trade mark team, which it describes as “brilliant” and the quality and experience of our two partners – Alasdair MacQuarrie and Rowena Price. The Review quotes: “London and Munich trademark attorney firm...

Read more

GJE is a Silver Partner at Biotech and Money London 2017

We are delighted to be a Silver Partner of the third annual Biotech and Money London 2017, which runs from 7-8 February 2017. Biotech and Money is a two-day congress helping build linkages and business opportunities for UK life science companies, capital and partners. The event will bring together 400...

Read more